SCHEMBL184757

SCHEMBL184757

O=C(O)c1ccc(NC(=O)C(OC2CCOC2)c2ccc(S(=O)(=O)C3CCOCC3)cc2)nc1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11972013 0.95 GCK (0.67) GCK
SCHEMBL624177 0.91 GCK (0.63) GCK
SCHEMBL623294 0.86 GCK (0.68) GCK
SCHEMBL624312 0.84 GCK (0.59) GCK
SCHEMBL624246 0.84 GCK (0.65) GCK
SCHEMBL11972359 0.83 GCK (0.65) GCK
SCHEMBL11997732 0.83 GCK (0.57) GCK
SCHEMBL11972122 0.83 GCK (0.64) GCK
SCHEMBL10140456 0.82 GCK (0.63) GCK
SCHEMBL11971716 0.82 GCK (0.59) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP claimed
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP disclosed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP disclosed